DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Mascarenhas J, Hoffman R, Talpaz M. et al.
Pacritinib vs best available therapy, including ruxolitinib, in patients with myelofibrosis: a randomized clinical trial.
JAMA Oncol 2018;
4 (05) 652-659
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.